The US Federal Trade Commission (FTC), along with more than 20 states, has filed a lawsuit against Amazon alleging deceptive practices related to advertising pricing. According to court documents released on Monday, Amazon allegedly raised minimum prices for advertisers secretly, causing billions in damages to customers. The case follows a similar dispute from last year where Amazon agreed to pay $2.5 billion in fines and refunds to Prime subscribers. Meanwhile, OpenAI reported that its advertising revenue reached $1 billion annually, expanding its ad platform to Europe, India, the Middle East, and North Africa. Analysts noted this figure might indicate OpenAI could miss its $2.5 billion advertising target by 2026. Lastly, Eli Lilly announced plans to acquire Merida Biosciences for up to $2.88 billion in cash to expand its autoimmune and allergy treatment portfolio.
Bias read (Center): The article reports on legal actions taken by the FTC and state governments against Amazon, which is a politically charged issue involving antitrust regulation. However, the article presents both sides of the allegations and outcomes without overtly favoring either Amazon or the regulators. It also





